1
|
Wolf B. Letter to the Editor with regards to the article: Biotinidase deficiency in a Newborn. J Neonatal Perinatal Med 2023; 16:191-192. [PMID: 37270813 DOI: 10.3233/npm-190372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Affiliation(s)
- B Wolf
- Department of Pediatrics, Genetics, Birth Defects and Metabolic Diseases, Lurie Children's Hospital of Chicago and Northwestern University-Feinberg School of Medicine, Chicago, IL, USA
| |
Collapse
|
2
|
Agarmani Y, Hartmann S, Zimmermann J, Gati E, Delleske C, Tutsch U, Wolf B, Lang M. Advanced technique for measuring relative length changes under control of temperature and helium-gas pressure. Rev Sci Instrum 2022; 93:113902. [PMID: 36461492 DOI: 10.1063/5.0099412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Accepted: 09/28/2022] [Indexed: 06/17/2023]
Abstract
We report the realization of an advanced technique for measuring relative length changes ΔL/L of mm-sized samples under the control of temperature (T) and helium-gas pressure (P). The system, which is an extension of the apparatus described in the work of Manna et al. [Rev. Sci. Instrum. 83, 085111 (2012)], consists of two 4He-bath cryostats, each of which houses a pressure cell and a capacitive dilatometer. The interconnection of the pressure cells, the temperature of which can be controlled individually, opens up various modes of operation to perform measurements of ΔL/L under the variation of temperature and pressure. Special features of this apparatus include the possibility (1) to increase the pressure to values far in excess of the external pressure reservoir, (2) to substantially improve the pressure stability during temperature sweeps, (3) to enable continuous pressure sweeps with both decreasing and increasing pressure, and (4) to simultaneously measure the dielectric constant of the pressure-transmitting medium, viz., helium, εr He(T,P), along the same T-P trajectory as that used for taking the ΔL(T, P)/L data. The performance of the setup is demonstrated by measurements of relative length changes (ΔL/L)T at T = 180 K of single crystalline NaCl upon continuously varying the pressure in the range 6 ≤ P ≤ 40 MPa.
Collapse
Affiliation(s)
- Y Agarmani
- Institute of Physics, Goethe University Frankfurt, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - S Hartmann
- Institute of Physics, Goethe University Frankfurt, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - J Zimmermann
- Institute of Physics, Goethe University Frankfurt, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - E Gati
- Institute of Physics, Goethe University Frankfurt, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - C Delleske
- Institute of Physics, Goethe University Frankfurt, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - U Tutsch
- Institute of Physics, Goethe University Frankfurt, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - B Wolf
- Institute of Physics, Goethe University Frankfurt, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| | - M Lang
- Institute of Physics, Goethe University Frankfurt, Max-von-Laue-Straße 1, 60438 Frankfurt am Main, Germany
| |
Collapse
|
3
|
Park J, Wai Meng D, Hollebecque A, Borad M, Goyal L, Schram A, Cassier P, Kamath S, Dotan E, Kim R, Sahai V, Liao CY, Millward M, Roda Perez D, Blakesley R, Wolf B, Subbiah V, Kelley R, Oh DY. 76MO Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA): ReFocus trial. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
4
|
Hollebecque A, Borad M, Goyal L, Schram A, Park J, Cassier P, Kamath S, Meng DW, Dotan E, Kim R, Sahai V, Oh DY, Liao CY, Millward M, Perez DR, Ferté C, Blakesley R, Wolf B, Subbiah V, Kelley R. LBA12 Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA): ReFocus trial. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.08.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
5
|
Akinbobola O, Faris N, Smeltzer M, Ray M, Fehnel C, Pacheco A, Saulsberry A, Dortch K, Wiggins H, Talton D, Eubanks R, Stevenson D, Valaulikar G, Patel H, Wolf B, Koury A, Levy P, Ng T, Robbins T, Osarogiagbon R. EP02.03-022 Evolution of Lung Cancer Resection Quality: A Prospective Staggered Implementation Quality Improvement Study. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
6
|
Heinz P, Hackenbroch C, Weihrauch M, Metrikat J, Hossfeld B, Wolf B. Akute Hemiparese infolge spontaner zervikaler intraspinaler Blutung – ein seltenes „stroke mimic“. Notf Rett Med 2022. [DOI: 10.1007/s10049-022-01047-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
7
|
Wolf B, Czajkowska M, Dorobisz A. Intraoperative Carotid Artery Injuries. Review of the literature, analysis of the material of one centre. Pol Przegl Chir 2022; 94:32-37. [PMID: 35485314 DOI: 10.5604/01.3001.0015.6901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
<b>Introduction:</b> Injuries of the carotid artery constitute a rare group of injuries. This study presents results of the treatment of 44 patients with iatrogenic carotid artery injuries for over 20 years. The patients were treated by the team of doctors of the Department of Vascular, General and Transplant Surgery in Wroclaw in the years 1997-2017 (Head of the Department Prof. Klemens Skóra, MD, and Prof. Piotr Szyber, MD, PhD - material used with permission). </br></br> <b>Aim:</b> Aims of the analysis are: to estimate the frequency of different forms of iatrogenic injuries to the common and internal carotid artery, to evaluate the results of treatment, to assess the most effective surgical method depending on the type of injury, and develop an effective preoperative, intraoperative and postoperative regimen.</br></br> <b>Discussion and results:</b> The frequency of various carotid artery injuries (blunt, acute, traffic) was constant between years, but the number of iatrogenic injuries definitely increased over time. The prognosis for patients with carotid artery injury, especially when combined with multi-organ trauma, is the gravest. Significantly better treatment results were achieved with both acute and iatrogenic injuries. This is mainly due to easier and quicker diagnosis and better conditions for assisting patients.</br></br> <b>Conclusions:</b> In iatrogenic injuries, a well-designed surgical scheme, i.e. primarily the administration of UTH and placing a temporary flow drain by the first operating team, reduces the risk of neurological complications.
Collapse
Affiliation(s)
- Barbara Wolf
- The Silesian Piasts' Medical University, Wroclaw, Poland
| | - Magda Czajkowska
- The Department of Pharmacy of the Regional Blood Donation Centre in Wroclaw, Poland
| | | |
Collapse
|
8
|
Abstract
<br><b>Introduction:</b> Injuries of the carotid artery constitute a rare group of injuries. This study presents results of the treatment of 44 patients with iatrogenic carotid artery injuries for over 20 years. The patients were treated by the team of doctors of the Department of Vascular, General and Transplant Surgery in Wroclaw in the years 1997–2017 (Head of the Department Prof. Klemens Skóra, MD, and Prof. Piotr Szyber, MD, PhD – material used with permission).</br>
<br><b>Aim:</b> Aims of the analysis are: to estimate the frequency of different forms of iatrogenic injuries to the common and internal carotid artery, to evaluate the results of treatment, to assess the most effective surgical method depending on the type of injury, and develop an effective preoperative, intraoperative and postoperative regimen.</br>
<br><b>Discussion and results:</b> The frequency of various carotid artery injuries (blunt, acute, traffic) was constant between years, but the number of iatrogenic injuries definitely increased over time. The prognosis for patients with carotid artery injury, especially when combined with multi-organ trauma, is the gravest. Significantly better treatment results were achieved with both acute and iatrogenic injuries. This is mainly due to easier and quicker diagnosis and better conditions for assisting patients.</br>
<br><b>Conclusions:</b> In iatrogenic injuries, a well-designed surgical scheme, i.e. primarily the administration of UTH and placing a temporary suction drain by the first operating team, reduces the risk of neurological complications.</br>
Collapse
Affiliation(s)
- Barbara Wolf
- The Silesian Piasts’ Medical University, Wroclaw
| | - Magda Czajkowska
- The Department of Pharmacy of the Regional Blood Donation Centre in Wroclaw, Poland
| | | |
Collapse
|
9
|
Wolf B, Jeliazkova-Mecheva V, Del Rio-Espinola A, Boisclair J, Walker D, Cochin De Billy B, Flaherty M, Flandre T. An afucosylated anti-CD32b monoclonal antibody induced platelet-mediated adverse events in a human Fcγ receptor transgenic mouse model and its potential human translatability. Toxicol Sci 2021; 185:89-104. [PMID: 34687301 DOI: 10.1093/toxsci/kfab124] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
To assess the safety and tolerability of NVS32b, a monoclonal, afucosylated, anti-CD32b (FCGR2B) antibody we used a humanized transgenic (Tg) mouse model that expresses all human Fc gamma receptors (FCGRs) while lacking all mouse FCGRs. Prior to its use, we extensively characterized the model. We found expression of all human FCGRs in a pattern similar to humans with some exceptions, such as low CD32 expression on T cells (detected with the pan CD32 antibody but more notably with the CD32b-specific antibody), variation in the transgene copy number, integration of additional human genes, and overall higher expression of all FCGRs on myeloid cells compared to human. Unexpectedly, NVS32b induced severe acute generalized thrombosis in huFCGR mice upon iv dosing. Mechanistic evaluation on huFCGR and human platelets revealed distinct binding, activation and aggregation driven by NVS32b in both species. In huFCGR mice, the anti-CD32b antibody NVS32b binds platelet CD32a via both Fc and/or CDR (complementarity determining region) causing their activation while in human, NVS32b-binding requires platelet pre-activation and interaction of platelet CD32a via the Fc portion and an unknown platelet epitope via the CDR portion of NVS32b. We deemed the huFCGR mice to be over-predictive of the NVS32b-associated human thrombotic risk. Impact: In this study we elucidated the mechanism based on the thrombotic adverse events observed in huFCGR mice upon NVS32B dosing and were able to identify this safety liability which led to program termination. Therefore, this mouse model could be useful in research of immunotherapies targeting or involving FCGRs. Potential biological implications resulting from species differences in the FCGR expression pattern are nevertheless important to consider.
Collapse
Affiliation(s)
- B Wolf
- Novartis Institutes for BioMedical Research, Basel, Switzerland
| | | | | | - J Boisclair
- Novartis Institutes for BioMedical Research, Basel, Switzerland
| | - D Walker
- Novartis Institutes for BioMedical Research, Cambridge, MA, USA
| | | | - M Flaherty
- Novartis Institutes for BioMedical Research, Cambridge, MA, USA
| | - T Flandre
- Novartis Institutes for BioMedical Research, Basel, Switzerland
| |
Collapse
|
10
|
Peterson BL, Arnall M, Avedschmidt S, Beers D, Bell M, Burton S, Case M, Catellier M, Cina S, Cohle S, Collins K, Covach A, Downs J, Ely E, Ely S, Fajardo M, Fierro M, Fowler D, Frost R, Fudenberg J, Fusaro A, Gill J, Gilson T, Glenn C, Goldfogel G, Graham S, John Greenwell P, Ann Grossberg L, Gulledge C, Handler M, Hansma P, Harshbarger K, Hawes A, Hellman F, Heninger M, Hlavaty L, Hoyer P, Johnson D, Jorden M, Kelley D, Kesha K, Kohr R, Krywanczyk A, Lehman L, Lochmuller C, Luzi S, Mathew A, McDonough E, Mileusnic D, Miller E, Milroy C, Morrow P, Oliver W, Orvik A, Pandey M, Parsons T, Pfalzgraf R, Philip A, Poulos C, Prahlow J, Pustilnik S, Radisch D, Rao V, Raven K, Resk T, Ross K, Rudd T, Schmidt C, Schmunk G, Ann Sens M, Shelly M, Snell K, Sperry K, Stables S, Stahl-Herz J, Steckbauer M, Super M, Tarau M, Thogmartin J, Tormos L, Tse R, Utley S, Vega R, Williams K, Wolf B, Wright R. Commentary on: Dror IE, Melinek J, Arden JL, Kukucka J, Hawkins S, Carter J, et al. Cognitive bias in forensic pathology decisions. J Forensic Sci. https://doi.org/10.1111/1556-4029.14697. Epub 2021 Feb 20. J Forensic Sci 2021; 66:2541-2544. [PMID: 34498736 DOI: 10.1111/1556-4029.14843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2021] [Accepted: 07/19/2021] [Indexed: 11/30/2022]
Affiliation(s)
| | | | | | - Dean Beers
- Associates in Forensic Investigations, LLC, Larimer, CO, USA
| | | | | | - Mary Case
- St. Louis County Medical Examiner's Office, St. Louis, MO, USA
| | | | - Stephen Cina
- Cina and Cina Forensic Consulting, PC, Loveland, CO, USA
| | - Stephen Cohle
- Kent County Medical Examiner Office, Grand Rapids, MI, USA
| | | | - Adam Covach
- Fond du Lac County Medical Examiner's Office, Fond du Lac, WI, USA
| | | | - Erin Ely
- St. Louis County Medical Examiner's Office, St. Louis, MO, USA
| | - Susan Ely
- Office of the Chief Medical Examiner, New York, NY, USA
| | - Mark Fajardo
- Riverside County Sheriff-Coroner's Office, Perris, CA, USA
| | | | | | | | - John Fudenberg
- Clark County Office of the Coroner/Medical Examiner, Las Vegas, NV, USA
| | - Aldo Fusaro
- Montana State Medical Examiner, Missoula, MT, USA
| | - James Gill
- Connecticut Office of the Chief Medical Examiner, Farmington, CT, USA
| | - Thomas Gilson
- Cuyahoga County Medical Examiner's Office, Cleveland, OH, USA
| | - Charles Glenn
- North Forensic Pathology Service, Auckland, New Zealand
| | - Gary Goldfogel
- Whatcom County Medical Examiner Office, Bellingham, WA, USA
| | | | | | | | | | - Michael Handler
- Neuropathology & Forensic Pathology Consulting Inc, Overland Park, KS, USA
| | | | | | - Amy Hawes
- Office of the Tennessee State Medical Examiner, Clinton, TN, USA
| | | | | | - Leigh Hlavaty
- Wayne County Medical Examiner's Office, Detroit, MI, USA
| | | | | | - Michelle Jorden
- Santa Clara County Medical Examiner's Office, San Jose, CA, USA
| | - Douglas Kelley
- Milwaukee County Medical Examiner's Office, Milwaukee, WI, USA
| | - Kilak Kesha
- North Forensic Pathology Service, Auckland, New Zealand
| | - Roland Kohr
- Terre Haute Regional Hospital, Terre Haute, IN, USA
| | | | - Lee Lehman
- Montgomery County Coroner's Office, Dayton, OH, USA
| | | | - Scott Luzi
- Anatomic, Clinical, and Forensic Pathology Services, Escondido, CA, USA
| | - Ashley Mathew
- Office of the State Medical Examiner, Louisville, KY, USA
| | | | | | | | - Chris Milroy
- Division of Anatomic Pathology, The Ottawa Hospital, Ottawa, Canada
| | - Paul Morrow
- North Forensic Pathology Service, Auckland, New Zealand
| | - William Oliver
- Knox County Regional Forensic Center, Knoxville, TN, USA
| | - Andrea Orvik
- Montana Medical Examiner's Office, Billings, MT, USA
| | | | - Thomas Parsons
- Lubbock County Medical Examiner's Office, Lubbock, TX, USA
| | | | - Abraham Philip
- Cobb County Medical Examiner's Office, Marietta, GA, USA
| | | | - Joe Prahlow
- Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA
| | | | | | - Valerie Rao
- District 12 Medical Examiner's Office, Sarasota, FL, USA
| | | | | | - Karen Ross
- Fort Bend County Medical Examiner's Office, Rosenberg, TX, USA
| | | | - Carl Schmidt
- Wayne County Medical Examiner's Office, Detroit, MI, USA
| | | | - Mary Ann Sens
- University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA
| | - Mark Shelly
- Maricopa County Office of the Medical Examiner, Phoenix, AZ, USA
| | - Kenneth Snell
- Minnehaha County Coroner/Medical Examiner's Office, Sioux Falls, SD, USA
| | - Kris Sperry
- Forensic Pathology Consultant, Peachtree City, GA, USA
| | - Simon Stables
- North Forensic Pathology Service, Auckland, New Zealand
| | - Jay Stahl-Herz
- New York City Office of the Chief Medical Examiner, Brooklyn, NY, USA
| | | | - Mark Super
- Super Forensic Pathology, El Dorado Hills, CA, USA
| | - Marius Tarau
- Jackson County Medical Examiner's Office, Kansas City, MO, USA
| | | | - Lee Tormos
- District 15 Medical Examiner's Office, Palm Beach, FL, USA
| | - Rexson Tse
- North Forensic Pathology Service, Auckland, New Zealand
| | - Suzanne Utley
- District 12 Medical Examiner's Office, Sarasota, FL, USA
| | - Russell Vega
- District 12 Medical Examiner's Office, Sarasota, FL, USA
| | | | - Barbara Wolf
- Districts 5 & 24 Medical Examiner's Office, Leesburg, FL, USA
| | | |
Collapse
|
11
|
Goyal L, Subbiah V, Mahipal A, Kamath S, Mody K, Borad M, El-Khoueiry A, Sahai V, Kim R, Kelley R, Schmidt-Kittler O, Shen J, Jen K, Deary A, Padval M, Sherwin C, Wolf B, Schram A. P-70 First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
12
|
Smeltzer M, Faris N, Lee Y, Fehnel C, Akinbobola O, Jones C, Meadows-Taylor M, Saulsberry A, Dox H, Eubanks R, Valaulikar G, Talton D, Wolf B, Wiggins H, Sievers E, Levy P, Robbins E, Ray M, Osarogiagbon R. MA09.08 Improving Overall Survival in Non-Small Cell Lung Cancer by Reducing R-Uncertain Resections With a Lymph Node Specimen Collection Kit. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
13
|
Killeen TK, Wolf B, Greer TL, Carmody T, Rethorst CD, Trivedi MH. Gender and racial/ethnic differences in physiologic responses in the Stimulant Reduction Intervention using Dosed Exercise Study. Addict Behav 2020; 110:106546. [PMID: 32688225 PMCID: PMC7416606 DOI: 10.1016/j.addbeh.2020.106546] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Revised: 05/31/2020] [Accepted: 07/05/2020] [Indexed: 10/23/2022]
Abstract
Exercise may be beneficial for individuals in substance use disorder (SUD) treatment given the higher rates of both medical and psychiatric comorbidity, namely mood and anxiety disorders, compared to the general population. Gender and/or racial/ethnic differences in health benefits and response to prescribed exercise have been reported and may have implications for designing exercise interventions in SUD programs. METHOD Data are from the National Drug Abuse Treatment Clinical Trials Network (NIDA/CTN) Stimulant Reduction Intervention using Dosed Exercise (STRIDE) trial. Gender differences across racial/ethnic groups in physiological responses and stimulant withdrawal severity across time were analyzed using linear mixed effects models. RESULTS Males completed significantly more exercise sessions than females and were more adherent to the prescribed exercise dose of 12 Kcal/Kg/Week. Controlling for age, race/ethnicity, treatment group and stimulant withdrawal severity, there was a significant gender by time interaction for body mass index (BMI) (p < 0.001), waist circumference (p < 0.001) and heart rate measured prior to exercise sessions (p < 0.01). For females, body mass index (BMI) and waist circumference increased over time while for males BMI and waist circumference stayed unchanged or slightly decreased with time. Heart rate over time significantly increased for females at a higher rate than in males. Stimulant withdrawal severity was similar in males and females at baseline but males exhibited a significant decrease over time while females did not. Although baseline differences were observed, there were no time by race/ethnicity differences in physiologic responses. DISCUSSION Gender differences in response to exercise may have implications for developing gender specific exercise interventions in SUD programs.
Collapse
Affiliation(s)
- T K Killeen
- Medical University of South Carolina, Charleston, SC, USA.
| | - B Wolf
- Medical University of South Carolina, Charleston, SC, USA
| | - T L Greer
- University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - T Carmody
- University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - C D Rethorst
- University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - M H Trivedi
- University of Texas Southwestern Medical Center, Dallas, TX, USA
| |
Collapse
|
14
|
Wolf B, Espig O, Stolzenburg JU, Horn LC, Aktas B, Höckel M. Preservation of the mesureter to reduce urinary complications: analysis of data from the observational Leipzig School MMR study. BJOG 2020; 127:859-865. [PMID: 32037645 DOI: 10.1111/1471-0528.16167] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/20/2020] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To evaluate the feasibility and effect of mesureteral preservation on urinary complications in the context of total mesometrial resection (TMMR), a surgical treatment for cervical cancer. DESIGN Retrospective cohort study with historic control. SETTING Single tertiary academic centre. POPULATION Women older than 18 with primary cervical cancer staged FIGO IB1-IIB enrolled in the prospective Leipzig School MMR study and underwent total mesometrial resection (TMMR) without adjuvant radiation. METHOD We retrospectively analysed 100 consecutive TMMR procedures which were performed for cancer of the uterine cervix and in which the mesureter was preserved (intervention group, 01/2014-06/2017). We compared this group with the previous 100 consecutive TMMRs, which were performed before the introduction of mesureteral preservation (control group, 09/2010-01/2014). MAIN OUTCOME MEASURES The occurrence of urological and specifically ureteral complications. RESULTS Mesureteral preservation was feasible and was associated with a significant decrease in ureteral complications (11% without mesureteral preservation versus 3% with mesureteral preservation, P = 0.049). Furthermore, we found a significant decrease in the number of postoperative percutaneous nephrostomies and re-operations (7% versus none, P = 0.014). There was also a trend towards a decrease in other urinary complications such as postoperative bladder atony and uretero-vaginal fistulas. CONCLUSION The mesureter constitutes a convenient dissection plane enabling the preservation of lateral ureteral blood supply during TMMR. In our study, maintenance of mesureteral integrity was associated with a significant reduction in ureteral complications. Mesureteral preservation might also be useful in other types of pelvic surgeries that carry a high risk of ureteral damage. TWEETABLE ABSTRACT Surgical preservation of the mesureter in cervical cancer patients was associated with a reduction in urinary complications.
Collapse
Affiliation(s)
- B Wolf
- Department of Gynaecology, University Hospital Leipzig, Leipzig, Germany
| | - O Espig
- Department of Urology, University Hospital Leipzig, Leipzig, Germany
| | - J-U Stolzenburg
- Department of Urology, University Hospital Leipzig, Leipzig, Germany
| | - L-C Horn
- Division of Gynaecologic, Breast, and Perinatal Pathology, University Hospital Leipzig, Leipzig, Germany
| | - B Aktas
- Department of Gynaecology, University Hospital Leipzig, Leipzig, Germany
| | - M Höckel
- Department of Gynaecology, University Hospital Leipzig, Leipzig, Germany
| |
Collapse
|
15
|
Gordon DT, Okuma K, DeVries JW, Fukuhara K, Jacob W, Kuriyama N, Li BW, Matsuda I, McMonagle K, Parr GD, Porter S, Strong S, Sugimoto T, Tsuji K, Wolf B. Determination of Total Dietary Fiber in Selected Foods Containing Resistant Maltodextrin by Enzymatic-Gravimetric Method and Liquid Chromatography: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/85.2.435] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
A method was developed for determination of total dietary fiber (TDF) in foods containing resistant maltodextrin (RMD) which includes nondigestible carbohydrates that are not fully recovered as dietary fiber by conventional TDF methods such as AOAC 985.29 or 991.43. Because the average molecular weight (MW) of RMD is 2000 daltons, lower MW soluble dietary fiber components do not precipitate in 78% ethanol; therefore, RMD is not completely quantitated as dietary fiber by current AOAC methods. The accuracy and precision of the method was evaluated through an AOAC collaborative study. Ten laboratories participated and assayed 12 test portions (6 blind duplicates) containing RMD. The 6 test pairs ranged from 1.5 to 100% RMD. The method consisted of the following steps: (1) The insoluble dietary fiber (IDF) and high MW soluble dietary fiber (HMWSDF) were determined by AOAC 985.29. (2) Ion exchange resins were used to remove salts and proteins contained in the AOAC 985.29 filtrates (including ethanol and acetone). (3) The amount of low MWRMD (LMWRMD) in the filtrates were determined by liquid chromatography. (4) The TDF was calculated by summation of the IDF, HMWSDF, and LMWRMD fractions having nondigestible carbohydrates with a degree of polymerization of 3 and higher. Repeatability standard deviations (RSDr) were 1.33–7.46%, calculated by including outliers, and 1.33–6.10%, calculated by not including outliers. Reproducibility standard deviations (RSDR) were 2.48–9.39%, calculated by including outliers, and 1.79–9.39%, calculated by not including outliers. This method is recommended for adoption as Official First Action.
Collapse
Affiliation(s)
- Dennis T Gordon
- North Dakota State University, Department of Cereal Science, Harris Hall 110, Fargo, ND 58105
| | - Kazuhiro Okuma
- Matsutani Chemical Industry Co., Ltd., Research Laboratory, 5-3 Kitaitami, Itami City, Hyogo, Japan 664-8508
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Mock A, Zschäbitz S, Kirsten R, Scheffler M, Wolf B, Herold-Mende C, Kramer R, Busch E, Jenzer M, Jäger D, Grüllich C. Serum very long-chain fatty acid-containing lipids predict response to immune checkpoint inhibitors in urological cancers. Cancer Immunol Immunother 2019; 68:2005-2014. [PMID: 31701161 DOI: 10.1007/s00262-019-02428-3] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2019] [Accepted: 11/01/2019] [Indexed: 01/26/2023]
Abstract
Checkpoint inhibitors (CPI) have significantly changed the therapeutic landscape of oncology. We adopted a non-invasive metabolomic approach to understand immunotherapy response and failure in 28 urological cancer patients. In total, 134 metabolites were quantified in patient sera before the first, second, and third CPI doses. Modeling the association between metabolites and CPI response and patient characteristics revealed that one predictive metabolite class (n = 9/10) were very long-chain fatty acid-containing lipids (VLCFA-containing lipids). The best predictive performance was achieved through a multivariate model, including age and a centroid of VLCFA-containing lipids prior to first immunotherapy (sensitivity: 0.850, specificity: 0.825, ROC: 0.935). We hypothesize that the association of VLCFA-containing lipids with CPI response is based on enhanced peroxisome signaling in T cells, which results in a switch to fatty acid catabolism. Beyond use as a novel predictive non-invasive biomarker, we envision that nutritional supplementation with VLCFA-containing lipids might serve as an immuno sensitizer.
Collapse
Affiliation(s)
- Andreas Mock
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| | - Stefanie Zschäbitz
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| | - Romy Kirsten
- Liquid Biobank, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany
| | | | | | - Christel Herold-Mende
- Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany
| | - Rebecca Kramer
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| | - Elena Busch
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| | - Maximilian Jenzer
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| | - Dirk Jäger
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany
| | - Carsten Grüllich
- Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. .,Department of Urology, Dresden University Hospital, Gustav Carus Fetscherstr. 74, 01307, Dresden, Germany.
| |
Collapse
|
17
|
Tutsch U, Tsyplyatyev O, Kuhnt M, Postulka L, Wolf B, Cong PT, Ritter F, Krellner C, Aßmus W, Schmidt B, Thalmeier P, Kopietz P, Lang M. Specific Heat Study of 1D and 2D Excitations in the Layered Frustrated Quantum Antiferromagnets Cs_{2}CuCl_{4-x}Br_{x}. Phys Rev Lett 2019; 123:147202. [PMID: 31702204 DOI: 10.1103/physrevlett.123.147202] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/22/2019] [Revised: 05/30/2019] [Indexed: 06/10/2023]
Abstract
We report an experimental and theoretical study of the low-temperature specific heat C and magnetic susceptibility χ of the layered anisotropic triangular-lattice spin-1/2 Heisenberg antiferromagnets Cs_{2}CuCl_{4-x}Br_{x} with x=0, 1, 2, and 4. We find that the ratio J^{'}/J of the exchange couplings ranges from 0.32 to ≈0.78, implying a change (crossover or quantum phase transition) in the materials' magnetic properties from one-dimensional (1D) behavior for J^{'}/J<0.6 to two-dimensional (2D) behavior for J^{'}/J≈0.78. For J^{'}/J<0.6, realized for x=0, 1, and 4, we find a magnetic contribution to the low-temperature specific heat, C_{m}∝T, consistent with spinon excitations in 1D spin-1/2 Heisenberg antiferromagnets. Remarkably, for x=2, where J^{'}/J≈0.78 implies a 2D magnetic character, we also observe C_{m}∝T. This finding, which contrasts the prediction of C_{m}∝T^{2} made by standard spin-wave theories, shows that Fermi-like statistics also plays a significant role for the magnetic excitations in spin-1/2 frustrated 2D antiferromagnets.
Collapse
Affiliation(s)
- U Tutsch
- Physikalisches Institut, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - O Tsyplyatyev
- Institut für Theoretische Physik, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - M Kuhnt
- Physikalisches Institut, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - L Postulka
- Physikalisches Institut, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - B Wolf
- Physikalisches Institut, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - P T Cong
- Physikalisches Institut, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - F Ritter
- Physikalisches Institut, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - C Krellner
- Physikalisches Institut, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - W Aßmus
- Physikalisches Institut, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - B Schmidt
- Max-Planck-Institut für Chemische Physik fester Stoffe, 01187 Dresden, Germany
| | - P Thalmeier
- Max-Planck-Institut für Chemische Physik fester Stoffe, 01187 Dresden, Germany
| | - P Kopietz
- Institut für Theoretische Physik, Goethe-Universität, 60438 Frankfurt (M), Germany
| | - M Lang
- Physikalisches Institut, Goethe-Universität, 60438 Frankfurt (M), Germany
| |
Collapse
|
18
|
Lambrecht L, Wobst J, Wolf B, Schunkert H, Kessler T. Platelet Inhibition In Carriers Of The Gucy1A3 Coronary Artery Disease Risk Allele. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
19
|
Trott S, Dornhöfer N, Höckel M, Aktas B, Wolf B. Lebensqualität nach operativer Behandlung des Vulvakarzinoms mittels Vulvafeldresektion und anatomischer Rekonstruktion. Geburtshilfe Frauenheilkd 2019. [DOI: 10.1055/s-0039-1692069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- S Trott
- Gynäkologie Universitätsfrauenklinik Leipzig
| | - N Dornhöfer
- Gynäkologie Universitätsfrauenklinik Leipzig
| | - M Höckel
- Gynäkologie Universitätsfrauenklinik Leipzig
| | - B Aktas
- Gynäkologie Universitätsfrauenklinik Leipzig
| | - B Wolf
- Gynäkologie Universitätsfrauenklinik Leipzig
| |
Collapse
|
20
|
Lia M, Wolf B, Horn LC, Höckel M, Aktas B. Die Aussagekraft der core-needle-Biopsie beim Zervixkarzinom. Eine retrospektive Analyse. Geburtshilfe Frauenheilkd 2019. [DOI: 10.1055/s-0039-1692075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- M Lia
- Klinik und Poliklinik für Frauenheilkunde, Universitätsklinikum Leipzig
| | - B Wolf
- Klinik und Poliklinik für Frauenheilkunde, Universitätsklinikum Leipzig
| | - LC Horn
- Klinik und Poliklinik für Frauenheilkunde, Universitätsklinikum Leipzig
| | - M Höckel
- Klinik und Poliklinik für Frauenheilkunde, Universitätsklinikum Leipzig
| | - B Aktas
- Klinik und Poliklinik für Frauenheilkunde, Universitätsklinikum Leipzig
| |
Collapse
|
21
|
Wolf B, Sodeikat P, Borte G, Horn LC, Höckel M, Aktas B. Präoperative Evaluation des Parametriums beim Zervixkarzinom. Geburtshilfe Frauenheilkd 2019. [DOI: 10.1055/s-0039-1692078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- B Wolf
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Leipzig
| | - P Sodeikat
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Leipzig
| | - G Borte
- Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Leipzig
| | - LC Horn
- Institut für Pathologie, Universitätsklinikum Leipzig
| | - M Höckel
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Leipzig
| | - B Aktas
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Leipzig
| |
Collapse
|
22
|
Green M, Mumma C, Wolf B, Nannini V. Age, gender and weight's role in pediatric sedations; ages 12 and under in the omfs clinic. Int J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.ijom.2019.03.883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
23
|
Stary V, Unterleuthner D, Wolf B, Talic M, Strobl J, Beer A, Dolznig H, Bergmann M. Irradiated cancer exosomes promote M1-like polarization of macrophages and enhance their anti-tumoral responses. Eur J Cancer 2019. [DOI: 10.1016/j.ejca.2019.01.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
24
|
Yuan B, Schafferer S, Tang Q, Scheffler M, Nees J, Heil J, Schott S, Golatta M, Wallwiener M, Sohn C, Koal T, Wolf B, Schneeweiß A, Burwinkel B. A plasma metabolite panel as biomarkers for early primary breast cancer detection. Int J Cancer 2019; 144:2833-2842. [PMID: 30426507 DOI: 10.1002/ijc.31996] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2018] [Revised: 09/19/2018] [Accepted: 10/16/2018] [Indexed: 01/14/2023]
Abstract
In recent years, metabolites have attracted substantial attention as promising novel biomarkers of various diseases. However, breast cancer plasma metabolite studies are still in their infancy. Here, we investigated the potential of metabolites to serve as minimally invasive, early detection markers of primary breast cancer. We profiled metabolites extracted from the plasma of primary breast cancer patients and healthy controls using tandem mass spectrometry (UHPLC-MS/MS and FIA-MS/MS). Two metabolites were found to be upregulated, while 16 metabolites were downregulated in primary breast cancer patients compared to healthy controls in both the training and validation cohorts. A panel of seven metabolites was selected by LASSO regression analysis. This panel could differentiate primary breast cancer patients from healthy controls, with an AUC of 0.87 (95% CI: 0.81 ~ 0.92) in the training cohort and an AUC of 0.80 (95% CI: 0.71 ~ 0.87) in the validation cohort. These significantly differentiated metabolites are mainly involved in the amino acid metabolism and breast cancer cell growth pathways. In conclusion, using a metabolomics approach, we identified metabolites that have potential value for development of a multimarker blood-based test to complement and improve early breast cancer detection. The panel identified herein might be part of a prescreening tool, especially for younger women or for closely observing women with certain risks, to facilitate decision making regarding which individuals should undergo further diagnostic tests. In the future, the combination of metabolites and other blood-based molecular marker sets, such as DNA methylation, microRNA, and cell-free DNA mutation markers, will be an attractive option.
Collapse
Affiliation(s)
- Baowen Yuan
- Molecular Biology of Breast Cancer, Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany.,Division of Molecular Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | | | - Qiuqiong Tang
- Molecular Biology of Breast Cancer, Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany.,Division of Molecular Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | | | - Juliane Nees
- National Center for Tumor Diseases (NCT), Heidelberg, Germany.,Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany
| | - Jörg Heil
- Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany
| | - Sarah Schott
- Molecular Biology of Breast Cancer, Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany
| | - Michael Golatta
- Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany
| | - Markus Wallwiener
- National Center for Tumor Diseases (NCT), Heidelberg, Germany.,Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany
| | - Christof Sohn
- Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany
| | | | | | - Andreas Schneeweiß
- National Center for Tumor Diseases (NCT), Heidelberg, Germany.,Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany
| | - Barbara Burwinkel
- Molecular Biology of Breast Cancer, Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany.,Division of Molecular Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| |
Collapse
|
25
|
Tick S, Cornut PL, De Bats F, Wolf B, Souied EH, Cohen SY. [Update from France Macula Federation: Treatment of Wet AMD]. J Fr Ophtalmol 2018; 41:862-867. [PMID: 30361178 DOI: 10.1016/j.jfo.2018.06.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2018] [Revised: 06/26/2018] [Accepted: 06/27/2018] [Indexed: 01/08/2023]
Abstract
PURPOSE To update the recommendations of the France Macula Federation for treatment of wet age-related macular degeneration (AMD). METHODS Analysis of literature and expert opinion. RESULTS The FFM recommends initiating anti-VEGF therapy as soon as possible after diagnosis of exudative AMD. There has been no major change in the last several years concerning the procedure of intravitreal injection itself. However, the litigious points are discussed: simultaneous bilateral injection; antibiotic therapy; medico-legal aspects. All anti-VEGF strategies possess advantages and limitations. The strategy should be left to the ophthalmologists' preference. However, the chosen strategy should be explained to patients and strictly followed. CONCLUSION The treatment of wet-AMD is more precisely codified than before. However, various strategies still coexist.
Collapse
Affiliation(s)
- S Tick
- Centre hospitalier national d'ophtalmologie des XV-XX, 28, rue de Charenton, 75012 Paris, France; Centre ophtalmologique Vincennes, 17, bis rue des Meuniers, 94300 Vincennes, France
| | - P-L Cornut
- Centre pôle vision, clinique du Val d'Ouest, Croix rousse, 39, chemin de la Vernique, 69130 Écully, France
| | - F De Bats
- Centre pôle vision, clinique du Val d'Ouest, Croix rousse, 39, chemin de la Vernique, 69130 Écully, France; Hôpital de la Croix-Rousse, 103 grande rue de la Croix-Rousse, 69004 Lyon, France
| | - B Wolf
- Centre ophtalmologique de la maison rouge, 6, rue de l'Église, 67000 Strasbourg, France
| | - E H Souied
- Service d'ophtalmologie et université Paris Est, 61, avenue du Général de Gaulle, 94000 Créteil, France
| | - S Y Cohen
- Service d'ophtalmologie et université Paris Est, 61, avenue du Général de Gaulle, 94000 Créteil, France; Centre ophthalmologique d'imagerie et de laser, 11, rue Antoine Bourdelle, 75015 Paris, France.
| |
Collapse
|
26
|
Lee Y, Smeltzer M, Ray M, Faris N, Fehnel C, Houston-Harris C, Akinbobola O, Ojeabulu P, Owen E, Eubanks R, Dox H, Talton D, Wiggins H, Wolf B, Levy P, Robbins E, Osarogiagbon R. P2.16-32 Survival Implications and Factors Associated with the Anatomic Level of Incomplete Non-Small-Cell Lung Cancer (NSCLC) Resection. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Nees J, Schott S, Schafferer S, Müller U, Rom J, Tang Q, Koal T, Wolf B, Scheffler M, Marmé F, Sohn C, Schneeweiss A, Burwinkel B. Identification of a blood based metabolomic classifer for the detection of ovarian cancer – MeDOC. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- J Nees
- University Womens Clinic, Heidelberg, Deutschland
- Molecular Biology of Breast Cancer, University Womens Clinic, Heidelberg, Deutschland
| | - S Schott
- University Womens Clinic, Heidelberg, Deutschland
| | - S Schafferer
- Biocrates Life Sciences AG, Innsbruck, Österreich
| | - U Müller
- Biocrates Life Sciences AG, Innsbruck, Österreich
| | - J Rom
- University Womens Clinic, Heidelberg, Deutschland
| | - Q Tang
- Molecular Biology of Breast Cancer, University Womens Clinic, Heidelberg, Deutschland
- Molecular Epidemiology, C080, German Cancer Research Center, DKFZ, Heidelberg, Deutschland
| | - T Koal
- Biocrates Life Sciences AG, Innsbruck, Österreich
| | - B Wolf
- Biocrates Life Sciences AG, Innsbruck, Österreich
| | - M Scheffler
- Biocrates Life Sciences AG, Innsbruck, Österreich
| | - F Marmé
- National Center for Tumor Diseases, Heidelberg, Deutschland
| | - C Sohn
- University Womens Clinic, Heidelberg, Deutschland
| | - A Schneeweiss
- National Center for Tumor Diseases, Heidelberg, Deutschland
| | - B Burwinkel
- Molecular Biology of Breast Cancer, University Womens Clinic, Heidelberg, Deutschland
- Molecular Epidemiology, C080, German Cancer Research Center, DKFZ, Heidelberg, Deutschland
| |
Collapse
|
28
|
Piotrowska Z, Isozaki H, Lennerz J, Digumarthy S, Gainor J, Marcoux N, Banwait M, Dias-Santagata D, Iafrate A, Mino-Kenudson M, Nagy R, Lanman R, Evans E, Clifford C, Wolf B, Hata A, Sequist L. MA26.03 Activity of Osimertinib and the Selective RET Inhibitor BLU-667 in an EGFR-Mutant Patient with Acquired RET Rearrangement. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.540] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
29
|
Smeltzer M, Faris N, Ray M, Fehnel C, Akinbobola O, Houston-Harris C, Ojeabulu P, Lee Y, Owen E, Eubanks R, Dox H, Talton D, Wiggins H, Wolf B, Levy P, Robbins E, Osarogiagbon R. P1.16-46 A Population-Based Validation Study of the Proposed ‘R-Factor’ Classification in a Lung Cancer-Endemic Region of the US. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
30
|
Faris N, Lee Y, Smeltzer M, Ray M, Fehnel C, Houston-Harris C, Akinbobola O, Ojeabulu P, Owen E, Eubanks R, Dox H, Talton D, Valaulikar G, Wiggins H, Wolf B, Levy P, Robbins E, Osarogiagbon R. MA25.05 Characteristics and Survival of Resected Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Mid-South Quality of Surgical Resection Cohort. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
31
|
Lisberg A, Cummings A, Goldman JW, Bornazyan K, Reese N, Wang T, Coluzzi P, Ledezma B, Mendenhall M, Hunt J, Wolf B, Jones B, Madrigal J, Horton J, Spiegel M, Carroll J, Gukasyan J, Williams T, Sauer L, Wells C, Hardy A, Linares P, Lim C, Ma L, Adame C, Garon EB. A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC. J Thorac Oncol 2018; 13:1138-1145. [PMID: 29874546 DOI: 10.1016/j.jtho.2018.03.035] [Citation(s) in RCA: 369] [Impact Index Per Article: 61.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2018] [Accepted: 03/25/2018] [Indexed: 12/26/2022]
Abstract
BACKGROUND Despite the significant antitumor activity of pembrolizumab in NSCLC, clinical benefit has been less frequently observed in patients whose tumors harbor EGFR mutations compared to EGFR wild-type patients. Our single-center experience on the KEYNOTE-001 trial suggested that pembrolizumab-treated EGFR-mutant patients, who were tyrosine kinase inhibitor (TKI) naïve, had superior clinical outcomes to those previously treated with a TKI. As TKI naïve EGFR-mutants have generally been excluded from pembrolizumab studies, data to guide treatment decisions in this patient population is lacking, particularly in patients with programmed death ligand 1 (PD-L1) expression ≥50%. METHODS We conducted a phase II trial (NCT02879994) of pembrolizumab in TKI naive patients with EGFR mutation-positive, advanced NSCLC and PD-L1-positive (≥1%, 22C3 antibody) tumors. Pembrolizumab was administered 200 mg every 3 weeks. The primary endpoint was objective response rate. Secondary endpoints included safety of pembrolizumab, additional pembrolizumab efficacy endpoints, and efficacy and safety of an EGFR TKI after pembrolizumab. RESULTS Enrollment was ceased due to lack of efficacy after 11 of 25 planned patients were treated. Eighty-two percent of trial patients were treatment naïve, 64% had sensitizing EGFR mutations, and 73% had PD-L1 expression ≥50%. Only 1 patient had an objective response (9%), but repeat analysis of this patient's tumor definitively showed the original report of an EGFR mutation to be erroneous. Observed treatment-related adverse events were similar to prior experience with pembrolizumab, but two deaths within 6 months of enrollment, including one attributed to pneumonitis, were of concern. CONCLUSIONS Pembrolizumab's lack of efficacy in TKI naïve, PD-L1+, EGFR-mutant patients with advanced NSCLC, including those with PD-L1 expression ≥50%, suggests that it is not an appropriate therapeutic choice in this setting.
Collapse
Affiliation(s)
- A Lisberg
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - A Cummings
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - J W Goldman
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - K Bornazyan
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - N Reese
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - T Wang
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - P Coluzzi
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - B Ledezma
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - M Mendenhall
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - J Hunt
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - B Wolf
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - B Jones
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - J Madrigal
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - J Horton
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - M Spiegel
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - J Carroll
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - J Gukasyan
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - T Williams
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - L Sauer
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - C Wells
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - A Hardy
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - P Linares
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - C Lim
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - L Ma
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - C Adame
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
| | - Edward B Garon
- David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California.
| |
Collapse
|
32
|
Faris N, Smeltzer M, Fehnel C, Houston-Harris C, Ojeabulu P, Akinbobola O, Ray M, Lee Y, Deese L, Owen E, Wolf B, Wiggins H, Mutrie C, Sachdev V, Levy P, Signore R, Robbins E, Osarogiagbon R. P2.16-019 Improving Survival with a Lymph Node (LN) Collection Kit for Non-Small Cell Lung Cancer (NSCLC) Resections. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
33
|
Kim R, Sarker D, Macarulla T, Yau T, Choo S, Meyer T, Hollebecque A, Whisenant J, Sung M, Yoon JH, Lim H, Zhu A, Park JW, Faivre S, Mazzaferro V, Shi H, Schmidt-Kittler O, Clifford C, Wolf B, Kang YK. Phase 1 safety and clinical activity of BLU-554 in advanced hepatocellular carcinoma (HCC). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx367] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Kessler T, Wobst J, Wolf B, Eckhold J, Vilne B, Hollstein R, Sager H, Aherrahrou R, Kastrati A, Bjoerkegren J, Erdmann J, Lusis A, Civelek M, Kaiser F, Schunkert H. P4471The 4q32.1 coronary artery disease locus influences disease risk via differential transcription factor binding. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
35
|
Langhorst J, Heldmann P, Henningsen P, Kopke K, Krumbein L, Lucius H, Winkelmann A, Wolf B, Häuser W. [Complementary and alternative procedures for fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]. Schmerz 2017; 31:289-295. [PMID: 28493227 DOI: 10.1007/s00482-017-0206-1] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
BACKGROUND The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017. METHODS The guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n =8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. A search of the literature for systematic reviews of randomized controlled trials of complementary and alternative therapies from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The strength of recommendations was formed by multiple step formalized procedures to reach a consensus. Efficacy, risks, patient preferences and applicability of available therapies were weighed up against each other. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines. RESULTS AND CONCLUSION Meditative movement therapies (e.g. qi gong, tai chi and yoga) are strongly recommended. Acupuncture and weight reduction in cases of obesity can be considered.
Collapse
Affiliation(s)
- J Langhorst
- Innere Medizin V (Naturheilkunde und integrative Medizin), Kliniken Essen-Mitte, Essen, Deutschland.
| | - P Heldmann
- Bundesverband selbstständiger Physiotherapeuten, Bochum, Deutschland
| | - P Henningsen
- Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Technische Universität München, München, Deutschland
| | - K Kopke
- Department Pflege und Management, Hochschule für angewandte Wissenschaft Hamburg, Hamburg, Deutschland
| | - L Krumbein
- RehaKlinikum Bad Säckingen, Bad Säckingen, Deutschland
| | - H Lucius
- Schmerzambulanz, Helios-Fachklinik Schleswig, Schleswig, Deutschland
| | - A Winkelmann
- Klinik und Poliklinik für Orthopädie, Physikalische Medizin und Rehabilitation, Klinikum der Universität München, München, Deutschland
| | - B Wolf
- Deutsche Fibromyalgie Vereinigung, Seckach, Deutschland
| | - W Häuser
- Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Technische Universität München, München, Deutschland.,Innere Medizin I, Klinikum Saarbrücken gGmbH, Saarbrücken, Deutschland
| |
Collapse
|
36
|
Wolf B, Handzel R, Horn LC, Einenkel J. Angiomyofibroblastom des hinteren Vaginalfornix – ein seltener Fall. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0037-1601502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Affiliation(s)
- B Wolf
- Universitätsfrauenklinik Leipzig
| | | | - LC Horn
- Institut für Pathologie, Universität Leipzig
| | | |
Collapse
|
37
|
Wolf B, Wiersbicki D, Wolfskämpf T, Höckel M, Steinke H. Die PAS-Reaktion zur Darstellung der ontogenetischen Kompartimentgrenzen in pelvinen Großflächenschnitten: eine neue Methode. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0037-1601496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Affiliation(s)
- B Wolf
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Gynäkologie
| | | | | | - M Höckel
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Gynäkologie
| | - H Steinke
- Institut für Anatomie, Universität Leipzig
| |
Collapse
|
38
|
Wolf B, Horn LC, Höckel M. Risikostratifizierung von FIGO II B Zervixkarzinomen mittels ontogenetischem Tumorstaging. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0037-1601503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Affiliation(s)
- B Wolf
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Gynäkologie
| | - LC Horn
- Institut für Pathologie, Universität Leipzig
| | - M Höckel
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Gynäkologie
| |
Collapse
|
39
|
Wolf B, Eckardt T, Höckel M. Adjuvante Chemotherapie nach TMMR/EMMR beim Zervixkarzinom mit Lymphknotenmetastasen. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0037-1601504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Affiliation(s)
- B Wolf
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Gynäkologie
| | - T Eckardt
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Gynäkologie
| | - M Höckel
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Gynäkologie
| |
Collapse
|
40
|
Wolf B, Ganzer R, Stolzenburg JU, Hentschel B, Horn LC, Höckel M. Die erweiterte mesometriale Resektion (EMMR): ein operatives Verfahren zur Behandlung des lokal fortgeschrittenen Zervixkarzinoms. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0037-1601501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Affiliation(s)
- B Wolf
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Gynäkologie
| | - R Ganzer
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Urologie
| | - JU Stolzenburg
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Urologie
| | - B Hentschel
- Institut für Statistik und medizinische Epidemiologie (IMISE), Universität Leipzig
| | - LC Horn
- Institut für Pathologie, Universität Leipzig
| | - M Höckel
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Gynäkologie
| |
Collapse
|
41
|
Wolf B, Schulze KD, Lorenz W. Dunkel- und Photostromspannungskurven an n-GaP in wäßrigen und aprotischen Lösungen. Bestimmung der Kinetik anodischer Prozesse mit Elektronen und Löchern. Z PHYS CHEM 2017. [DOI: 10.1515/zpch-1982-263159] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
42
|
Heinrich M, Jones R, Schoffski P, Bauer S, von Mehren M, Eskens F, Cassier P, Mir O, Shi H, Alvarez-Diez T, Healy M, Wolf B, George S. Preliminary safety and activity in a first-in-human phase 1 study of BLU-285, a potent, highly-selective inhibitor of KIT and PDGFRα activation loop mutants in advanced gastrointestinal stromal tumor (GIST). Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)32612-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
43
|
Kim R, Sharma S, Meyer T, Sarker D, Macarulla T, Sung M, Choo S, Shi H, Schmidt-Kittler O, Clifford C, Wolf B, Llovet J. First-in-human study of BLU-554, a potent, highly-selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)32704-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
44
|
Wolf B, Goebel G, Hackl H, Fiegl H. Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients. BMC Cancer 2016; 16:821. [PMID: 27770790 PMCID: PMC5075160 DOI: 10.1186/s12885-016-2840-x] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2016] [Accepted: 10/05/2016] [Indexed: 12/30/2022] Open
Abstract
Background The transcription factor nuclear factor erythroid 2-related factor 2 (NFE2L2; previously known as NRF2) is a crucial regulator of the intracellular antioxidant response. It controls the expression of genes involved in the detoxification and elimination of reactive oxidants and electrophilic agents. The role of NFE2L2 in cancer is subject of controversial discussion, as it has been reported to have both pro-and anti-tumourigenic functions. To shed some light on this paradox, we analysed the NFE2L2 mRNA expression levels in breast cancer and its association with clinicopathological features and survival. Methods We retrospectively evaluated the NFE2L2 mRNA expression levels in tumour tissue of two independent breast cancer patient cohorts. In the training set we analysed data from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC). In the test set we measured the NFE2L2 mRNA expression levels in 176 breast tumour tissues by quantitative real-time reverse transcription PCR (qRT-PCR). Group differences were analysed using Mann–Whitney U-test, and associations between NFE2L2 mRNA expression levels and clinicopathological features were examined by means of univariate and multivariate survival analyses. Furthermore, we compared NFE2L2 mRNA expression levels between tumour and normal breast tissue samples by means of 108 paired samples from the The Cancer Genome Atlas (TCGA) dataset. Results In the training set we identified an independent predictive value for high NFE2L2 mRNA expression levels [HRdisease specific death 0.8 (0.6–1.0), P = 0.041; HRdeath 0.8 (0.6–1.0), P = 0.023] especially in the subgroup of oestrogen receptor (ER) positive tumours [HRdisease specific death 0.6 (0.4–0.9), P = 0.008; HRdeath 0.6 (0.4–0.8), P = 0.001]. Similarly, we found this association also in the test set [HRrelapse 0.4 (0.2–0.9), P = 0.031] and again, more pronounced in patients with ER positive tumours [HRrelapse 0.2 (0.1–0.7), P = 0.012]. In addition, we observed generally lower NFE2L2 expression levels in tumour tissues than in normal breast tissues. Conclusion We concluded that reduced NFE2L2 mRNA expression in tumour tissues is an independent predictor of shortened survival in breast cancer patients.
Collapse
Affiliation(s)
- Barbara Wolf
- Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria
| | - Georg Goebel
- Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, 6020, Innsbruck, Austria
| | - Hubert Hackl
- Division of Bioinformatics, Biocenter, Medical University of Innsbruck, 6020, Innsbruck, Austria
| | - Heidi Fiegl
- Department of Obstetrics and Gynaecology, Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
| |
Collapse
|
45
|
Abstract
A thirty-four-year-old man presented with symptoms of carotid occlusive disease. Work-up revealed 90% stenosis of the left internal carotid artery, which was found to be caused by a heretofore undescribed web of the carotid artery. The patient was treated with operative excision of the web and patch angio plasty of the carotid artery.
Collapse
Affiliation(s)
- Karl J. Karlson
- Overholt Cardiothoracic Surgical Associates and the Departments of Cardiovascular and Thoracic Surgery and Pathology, New England Deaconess Hospital and Harvard Medical School, Boston, Massachusetts
| | - Barbara Wolf
- Overholt Cardiothoracic Surgical Associates and the Departments of Cardiovascular and Thoracic Surgery and Pathology, New England Deaconess Hospital and Harvard Medical School, Boston, Massachusetts
| | - Wilford B. Neptune
- Overholt Cardiothoracic Surgical Associates and the Departments of Cardiovascular and Thoracic Surgery and Pathology, New England Deaconess Hospital and Harvard Medical School, Boston, Massachusetts
| |
Collapse
|
46
|
Niemier K, Schindler M, Volk T, Baum K, Wolf B, Eberitsch J, Seidel W. [Study on epidural steroid injection]. Schmerz 2015; 30:94-6. [PMID: 26589713 DOI: 10.1007/s00482-015-0078-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- K Niemier
- Klinik für Manuelle Therapie Hamm, Ostenallee 83, 59071, Hamm, Deutschland.
| | - M Schindler
- Krankenhaus Henningsdorf, Henningsdorf, Deutschland
| | - T Volk
- Universitätsklinikum des Saarlandes, Homburg, Deutschland
| | - K Baum
- Krankenhaus Henningsdorf, Henningsdorf, Deutschland
| | - B Wolf
- Sanaklinken Sommerfeld, Kremmen, Deutschland
| | - J Eberitsch
- Sanaklinken Sommerfeld, Kremmen, Deutschland
| | - W Seidel
- Sanaklinken Sommerfeld, Kremmen, Deutschland
| |
Collapse
|
47
|
Barton L, Wolf B, Rowlings D, Scheer C, Kiese R, Grace P, Stefanova K, Butterbach-Bahl K. Sampling frequency affects estimates of annual nitrous oxide fluxes. Sci Rep 2015; 5:15912. [PMID: 26522228 PMCID: PMC4629121 DOI: 10.1038/srep15912] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2015] [Accepted: 10/02/2015] [Indexed: 11/20/2022] Open
Abstract
Quantifying nitrous oxide (N2O) fluxes, a potent greenhouse gas, from soils is necessary to improve our knowledge of terrestrial N2O losses. Developing universal sampling frequencies for calculating annual N2O fluxes is difficult, as fluxes are renowned for their high temporal variability. We demonstrate daily sampling was largely required to achieve annual N2O fluxes within 10% of the ‘best’ estimate for 28 annual datasets collected from three continents—Australia, Europe and Asia. Decreasing the regularity of measurements either under- or overestimated annual N2O fluxes, with a maximum overestimation of 935%. Measurement frequency was lowered using a sampling strategy based on environmental factors known to affect temporal variability, but still required sampling more than once a week. Consequently, uncertainty in current global terrestrial N2O budgets associated with the upscaling of field-based datasets can be decreased significantly using adequate sampling frequencies.
Collapse
Affiliation(s)
- L Barton
- Soil Biology and Molecular Ecology Group, School of Earth &Environment (M087), UWA Institute of Agriculture, Faculty of Sciences, The University of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australia
| | - B Wolf
- Karlsruhe Institute of Technology, Institute for Meteorology and Climate Research Atmospheric Environmental Research (IMK-IFU), Kreuzeckbahnstr. 19, 82467 Garmisch-Partenkirchen, Germany
| | - D Rowlings
- Institute for Future Environments, Queensland University of Technology, 2 George Street, Brisbane, Queensland 4000, Australia
| | - C Scheer
- Institute for Future Environments, Queensland University of Technology, 2 George Street, Brisbane, Queensland 4000, Australia
| | - R Kiese
- Karlsruhe Institute of Technology, Institute for Meteorology and Climate Research Atmospheric Environmental Research (IMK-IFU), Kreuzeckbahnstr. 19, 82467 Garmisch-Partenkirchen, Germany
| | - P Grace
- Institute for Future Environments, Queensland University of Technology, 2 George Street, Brisbane, Queensland 4000, Australia
| | - K Stefanova
- UWA Institute of Agriculture (M089), The University of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australia
| | - K Butterbach-Bahl
- Karlsruhe Institute of Technology, Institute for Meteorology and Climate Research Atmospheric Environmental Research (IMK-IFU), Kreuzeckbahnstr. 19, 82467 Garmisch-Partenkirchen, Germany.,International Livestock Research Institute (ILRI), Nairobi, Kenya
| |
Collapse
|
48
|
Paulzen M, Gründer G, Veselinovic T, Wolf B, Hiemke C, Lammertz S. Duloxetine enters the brain – but why is it not found in the cerebrospinal fluid. Pharmacopsychiatry 2015. [DOI: 10.1055/s-0035-1557983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
49
|
Exner R, Pulverer W, Wolf B, Bergmann M, Weinhausel A, Egger G. 2198 DNA methylation in rectal cancer: A new diagnostic and prognostic biomarker panel. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31117-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Maecken T, Heite L, Wolf B, Zahn PK, Litz RJ. Ultrasound-guided catheterisation of the subclavian vein: freehand vs needle-guided technique. Anaesthesia 2015; 70:1242-9. [PMID: 26316098 DOI: 10.1111/anae.13187] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/10/2015] [Indexed: 11/30/2022]
Abstract
The objective of this prospective, randomised study was to examine the impact of a multi-angle needle guide for ultrasound-guided, in-plane, central venous catheter placement in the subclavian vein. One hundred and sixty patients were randomly allocated to two groups, freehand or needle-guided, and then 159 catheterisations were analysed. Cannulation of the first examined access site was successful in 96.9% of cases with no significant difference between groups. There were three arterial punctures and no other severe injuries. Catheter misplacements did not differ between the groups. Higher success rates within the first and second attempts in the needle-guided group were observed (p = 0.041 and p = 0.019, respectively). Use of the needle guide reduced the access time from a median (IQR [range]) of 30 (18-76 [6-1409]) s to 16 (10-30 [4-295]) s; p = 0.0001, and increased needle visibility from 31.8% (9.7%-52.2% [0-96.67]) to 86.2% (62.5%-100% [0-100]); p < 0.0001. A multi-angle needle guide significantly improved aligning the needle and ultrasound plane compared with the freehand technique when cannulating the subclavian vein. Use of the guide resulted in faster access times and increased success at the first and second attempts.
Collapse
Affiliation(s)
- T Maecken
- Department of Anaesthesiology, Intensive Care, Palliative Care and Pain Medicine, BG University Hospital Bergmannsheil, Bochum, Germany
| | - L Heite
- Department of Anaesthesiology, Intensive Care, Palliative Care and Pain Medicine, BG University Hospital Bergmannsheil, Bochum, Germany
| | - B Wolf
- Department of Anaesthesiology, Intensive Care, Palliative Care and Pain Medicine, BG University Hospital Bergmannsheil, Bochum, Germany
| | - P K Zahn
- Department of Anaesthesiology, Intensive Care, Palliative Care and Pain Medicine, BG University Hospital Bergmannsheil, Bochum, Germany
| | - R J Litz
- Department of Anaesthesiology, Intensive Care, Palliative Care and Pain Medicine, BG University Hospital Bergmannsheil, Bochum, Germany
| |
Collapse
|